Please assess the completion status of the following clinical trial:

Trial Title: Impact of Transjugular Intrahepatic Portosystemic Shunts on Liver Stiffness

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Symptomatic portal hypertension secondary to cirrhosis undergoing elective outpatient TIPS~* Age \>18, Age \<80~* Capable of giving informed consent~Exclusion Criteria:~* Coagulopathy defined as international normalized ration (INR) \>2 which cannot be corrected with fresh frozen plasma~* Platelet count \<50,000/microliter, which cannot be corrected with platelet transfusion~* BMI \>35 and/or cirrhosis due to non-alcoholic steatohepatitis (due to inaccurate elastography measurements in patients with fatty liver)~* Urgent or emergent TIPS for bleeding~* Portal vein thrombosis with in the main, 1st, or 2nd order branches of the portal vein~* Hepatic vein thrombosis (ie no Budd Chiari syndrome)~* Excessive alcohol use defined as more than 2 oz in 24 hours on any individual day within the last 30 days~* Inability to provide informed consent~* Pregnant or nursing women~* Enrollment in concurrent therapeutic trial for symptomatic portal hypertension

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- Open Label (Type: OTHER): All enrolled participants will undergo hepatic ultrasound with acoustic radiation force impulse (ARFI) before and 30 days after creation of TIPS.

Based on this trial design, predict the completion outcome and termination type (if applicable).